Work

A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.tps5597

Authors: Atish Dipankar Choudhury, Wanling Xie, Mamta Parikh, Daniel Lee, Elizabeth R Kessler, David Johnson Einstein, Bose Kochupurakkal, Kent William Mouw, Eliezer Mendel Van Allen, L. Austin Doyle, Alan D. D'Andrea, Mary-Ellen Taplin, Geoffrey Shapiro

Institutions: Dana-Farber Cancer Institute, UC Davis Comprehensive Cancer Center, National Cancer Institute, University of Colorado Anschutz, Beth Israel Deaconess Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3008617549

Cites:

Cited by: 3

Related to: 10